UK markets closed

Evelo Biosciences, Inc. (EVLO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0495+0.0076 (+18.14%)
As of 09:30AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
47,940
68,441
68,857
Total cash
47,940
68,441
68,857
Other current assets
3,633
2,585
2,123
Total current assets
51,573
71,026
70,980
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
21,045
23,166
23,878
Accumulated depreciation
-9,335
-7,634
-5,643
Net property, plant and equipment
11,710
15,532
18,235
Other long-term assets
1,158
1,313
1,424
Total non-current assets
12,868
16,845
19,659
Total assets
64,441
87,871
90,639
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,764
1,601
1,442
Accrued liabilities
6,754
6,656
10,634
Other current liabilities
427
742
463
Total current liabilities
12,395
17,362
19,833
Non-current liabilities
Long-term debt
43,614
46,557
30,048
Deferred revenues
7,500
7,500
0
Other long-term liabilities
659
-
284
Total non-current liabilities
57,038
61,842
40,321
Total liabilities
69,433
79,204
60,154
Stockholders' equity
Common stock
111
54
47
Retained earnings
-529,222
-414,695
-292,519
Total stockholders' equity
-4,992
8,667
30,485
Total liabilities and stockholders' equity
64,441
87,871
90,639